Evidence map›Paper›PMID 27453651›Full record

ArticleUrology annals

Urolithiasis and crohn's disease.

Sandro Roberto da Silva Gaspar, Tiago Mendonça, Pedro Oliveira, Tiago Oliveira, José Dias, Tomé Lopes

Open access · goldAbstract read
In one paragraph

Article in Urology annals. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Exercise in Clinical Reasoning: Trust but Verify.Journal of general internal medicine · 2022
    Article
  11. Renal Manifestations in Inflammatory Bowel Disease: A Cohort Study During the Biologic Era.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sandro Roberto da Silva GasparDepartment of Urology, Hospital Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal.
Tiago MendonçaDepartment of Urology, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
Pedro OliveiraDepartment of Urology, Hospital Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal.
Tiago OliveiraDepartment of Urology, Hospital Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal.
José DiasDepartment of Urology, Hospital Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal.
Tomé LopesDepartment of Urology, Hospital Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal.
Centro Hospitalar Lisboa Norte · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo present an updated description of the relation between Crohn's disease (CD) and Urolithiasis. PATIENTS AND

methodsA literature search for English-language original and review articles was conducted in Medline, Embase, and Cochrane databases in the month of December 2014 for papers either published or e-published up to that date, addressing the association between CD and urolithiasis as its consequence. All articles published in English language were selected for screening based on the following search terms: "CD," "renal calculus," "IBD," and "urolithiasis." We restricted the publication dates to the last 15 years (2000-2014).

resultsIn total, 901 patients were included in this review of which 95 were identified as having CD and urolithiasis simultaneously, for a total of 10.5%. Average age was 45.07 years old, irrespective of gender. 28.6% of patients received some kind of medical intervention without any kind of surgical technique involved, 50% of patients were submitted to a surgical treatment, and the remaining 21.4% were submitted to a combination of surgical and medical treatment. Urolithiasis and pyelonephritis incidence ranged from 4% to 23% with a risk 10-100 times greater than the risk for general population or for patients with UC, being frequent in patients with ileostomy and multiple bowel resections. We found that urolithiasis occurred in 95 patients from a total of 901 patients with CD (10.5%); 61.81% in men and 38.19% in women. Stone disease seems to present approximately 4-7 years after the diagnosis of bowel disease and CaOx seems to be the main culprit.

conclusionsCD is a chronic, granulomatous bowel disease, with urolithiasis as the most common extraintestinal manifestation (EIM), particularly frequent in patients submitted to bowel surgery. This complication needs to be recognized and addressed appropriately, especially in patients with unexplained renal dysfunction, abdominal pain, or recurrent urinary tract infection. We believe this study to be an updated valuable review as most data related to this kind of EIM refers to articles published before 2000, most of them before 1990. These patients need to be followed up with a specific prevention plan to eliminate or mitigate the risk factors for stone disease, aiming at preventing its formation and its complications, preserving renal function, reducing morbidity, and ultimately improving their quality of life.

Indexed as

Calcium oxalate stonesCrohn's diseaseextraintestinal manifestationsinflammatory bowel diseaseulcerative colitis

Identifiers

PMID27453651
PMCPMC4944622
OpenAlexW2462048519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.